United States · Biotechnology startup

Grail

Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.

Funding reportedLast round: Series D

BiotechnologyMenlo Park, United States

What company datasets say Grail raised

Funding, as reported

Reported in all$2.0Bin dollars
Rounds5
Last roundSeries D
Last round dateMay 2020
Investors listed24

On 6 portfolio pages

Investors who name them

Each firm lists Grail on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Grail in front of investors. Or tell us what we have wrong.

List your startupSend a correction